Agenda:
15 March 2005
08.45 - 09.00
Chairman's Opening Welcome Address
Session 1
09.00 - 09.20
Keynote Address: The state of the industry to date: exploring the growing role of CRO’s
Dr Christopher Milne, Assistant Director, Tufts Centre for Drug Development
09.20 - 10.00
Designing your own trials
Moderator: Ilonna Rimm, Oxford Bioscience
Discussants:
Dr Richard Kuntz, MD, MSc., HCRI
Dr David Cohen, MD, HCRI
Dr Paul Bleicher, Phase Forward
Session 2
10.00 - 11.00
Panel Discussion: Working with CRO’s:
The Value Proposition of Outsourced Clinical Research
Discussants:
Dr. Larry Blankstein,
Senior Director, Clinical Research, Genzyme
Alex Milstein,
Director, Clinical Research and Development, Medtronic Vascular
Dr Steven Chmielewski,
Manager, Project Management Excellent, Preferred CRO Partnerships, Eli Lilly
Spencer Goldsmith,
President, Harvard Clinical Research Institute
11.00
Coffee Break
Session 3
11.20 - 12.00
Winning Strategies – The Road to Drug Approval
Moderator: Tom Sommer, President, MassMEDIC
Discussants:
Don Baim, MD, Brigham & Women’s Hospital
Nancy Briefs, CEO, Percardia
Kevin Connors, Spray Partners
Session 4
12.00 - 13.00
Panel Discussion: Global Regulatory Issues
Discussants:
Dennis LaCroix, Director & Senior Counsel, Clinical Contracts & Vendor Management, Genzyme
Maria Buckley, Nutter McClennen & Fish LLP
13.00
Lunch
Session 5
14.15 - 15.30
Panel Discussion:
The science of alliances: Picking the right partner for clinical trials.
Discussants:
Ann Wang, Vice President, Clinical Operations, Human Genome Sciences Inc
Lynn McGovern, Director Outsourcing, Synta Pharmaceuticals Group
15.30
Coffee
Session 6
15.50 - 17.00
Panel Discussion: Global Outsourcing for International Trials
Moderator: Dr Peter Kalinka, Managing Director, Accelsiors Group
Discussants:

Mark Engel, President & CEO, Excel PharmaStudies
Alek Safarian, CEO, Novotech
17.10 - 17.20
Chairman’s Closing Remarks
17.30
Cocktail Reception
 

*Speaker to be confirmed

To download a pdf version of this agenda click here.

Back to top